Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?

Have shares of the troubled life sciences business fallen too far? To say the past year has been rough for investors in Ginkgo Bioworks (DNA -13.85%) would be an understatement of the highest order. As of Aug 14, shares of the synthetic-biology stock were down by 86% in 2024. A beaten-down price isn't the only way the stock market has signaled low expectations. Ginkgo stock has been trading at a steeply negative enterprise value. It's a debt-free company that finished June with $730 million in cash and cash ...